ProfileGDS4718 / 229183_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 39% 43% 40% 48% 40% 32% 34% 49% 43% 42% 36% 37% 40% 34% 30% 39% 38% 37% 34% 36% 46% 38% 41% 41% 41% 31% 40% 35% 40% 35% 34% 32% 45% 37% 38% 30% 34% 40% 44% 35% 38% 36% 38% 35% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9584339
GSM549102patient 115, normal, homogenized [OPG study]5.1638943
GSM549104patient 119, normal, homogenized [OPG study]5.0050140
GSM549108patient 138, normal, homogenized [OPG study]5.4648848
GSM549119patient 077, normal, homogenized [OPG study]4.9908140
GSM549133patient 032, cancer, homogenized [OPG study]4.5834832
GSM549139patient 042, cancer, homogenized [OPG study]4.7060934
GSM549099patient 107, normal, homogenized [OPG study]5.4686849
GSM549109patient 139, normal, homogenized [OPG study]5.1581643
GSM549110patient 046, normal, homogenized [OPG study]5.105842
GSM549114patient 063, normal, homogenized [OPG study]4.784736
GSM549122patient 082, normal, homogenized [OPG study]4.8622937
GSM549134patient 033, cancer, homogenized [OPG study]4.9568540
GSM549136patient 036, cancer, homogenized [OPG study]4.6386734
GSM549140patient 044, cancer, homogenized [OPG study]4.5159930
GSM549111patient 047, normal, homogenized [OPG study]4.9290539
GSM549113patient 057, normal, homogenized [OPG study]4.8526338
GSM549132patient 031, cancer, homogenized [OPG study]4.8506537
GSM549137patient 038, cancer, homogenized [OPG study]4.704834
GSM549142patient 047, cancer, homogenized [OPG study]4.9440936
GSM549100patient 110, normal, homogenized [OPG study]5.3141746
GSM549107patient 135, normal, homogenized [OPG study]4.8704238
GSM549115patient 068, normal, homogenized [OPG study]4.9615641
GSM549116patient 072, normal, homogenized [OPG study]5.016841
GSM549120patient 078, normal, homogenized [OPG study]5.0519541
GSM549131patient 030, cancer, homogenized [OPG study]4.5322831
GSM549118patient 074, normal, homogenized [OPG study]4.9780340
GSM549129patient 027, cancer, homogenized [OPG study]4.7919835
GSM549123patient 088, normal, homogenized [OPG study]4.9804640
GSM549124patient 006, cancer, homogenized [OPG study]4.8218735
GSM549126patient 015, cancer, homogenized [OPG study]4.6855534
GSM549128patient 025, cancer, homogenized [OPG study]4.595532
GSM549103patient 117, normal, homogenized [OPG study]5.3135345
GSM549117patient 073, normal, homogenized [OPG study]4.8266337
GSM549138patient 041, cancer, homogenized [OPG study]4.8869638
GSM549141patient 045, cancer, homogenized [OPG study]4.4970530
GSM549130patient 028, cancer, homogenized [OPG study]4.7106134
GSM549101patient 111, normal, homogenized [OPG study]5.0258540
GSM549105patient 128, normal, homogenized [OPG study]5.2115144
GSM549106patient 134, normal, homogenized [OPG study]4.7156235
GSM549112patient 048, normal, homogenized [OPG study]4.8773538
GSM549125patient 011, cancer, homogenized [OPG study]4.8057736
GSM549127patient 024, cancer, homogenized [OPG study]4.8824738
GSM549135patient 035, cancer, homogenized [OPG study]4.7059435